Blue light-filtering IOL option for cataract surgery

Article

Anaheim, CA-Although longer follow-up is needed to determine whether the pseu-dophakic, blue light-filter-ing IOL (AcrySof Natural, Alcon) reduces the risk of progression of age-related macular degeneration (AMD), available indirect evidence provides sufficient sup-port to advocate its use in cataract surgery, said Robert J. Cionni, MD.

Recent Videos
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
© 2024 MJH Life Sciences

All rights reserved.